UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage

Cancer research (Chicago, Ill.), 2015-04, Vol.75 (7), p.1311-1321

2015

Volltextzugriff (PDF)

Prognostic value of FDG-PET and DWI in breast cancer

Annals of nuclear medicine, 2018-01, Vol.32 (1), p.44-53

2018

Volltextzugriff (PDF)

Significant association between high serum CCL5 levels and better disease‐free survival of patients with early breast cancer

Cancer science, 2020-01, Vol.111 (1), p.209-218

2020

Volltextzugriff (PDF)

Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage

Cancer science, 2015-08, Vol.106 (8), p.1050-1056

2015

Volltextzugriff (PDF)

Ribociclib for HR-Positive, Advanced Breast Cancer

The New England journal of medicine, 2017-01, Vol.376 (3), p.288-289

2017

Volltextzugriff (PDF)

Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women

Clinical cancer research, 2007-01, Vol.13 (2), p.408-414

2007

Volltextzugriff (PDF)

HP1 regulates the localization of FANCJ at sites of DNA double‐strand breaks

Cancer science, 2016-10, Vol.107 (10), p.1406-1415

2016

Volltextzugriff (PDF)

Therapeutic advances in BIG3‐PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer

Cancer science, 2015-05, Vol.106 (5), p.550-558

2015

Volltextzugriff (PDF)

Association of Serum Adiponectin Levels with Breast Cancer Risk

Clinical cancer research, 2003-11, Vol.9 (15), p.5699-5704

2003

Volltextzugriff (PDF)

Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers

Clinical cancer research, 2005-02, Vol.11 (4), p.1380-1385

2005

Volltextzugriff (PDF)

Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling

Journal of clinical oncology, 2005-01, Vol.23 (3), p.422-431

2005

Volltextzugriff (PDF)

High Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast Cancer

Clinical cancer research, 2005-12, Vol.11 (23), p.8425-8430

2005

Volltextzugriff (PDF)

High expression of ubiquitin carboxy‐terminal hydrolase‐L1 and ‐L3 mRNA predicts early recurrence in patients with invasive breast cancer

Cancer science, 2006-06, Vol.97 (6), p.523-529

2006

Volltextzugriff (PDF)

High Expression of Wilms’ Tumor Suppressor Gene Predicts Poor Prognosis in Breast Cancer Patients

Clinical cancer research, 2002-05, Vol.8 (5), p.1167-1171

2002

Volltextzugriff (PDF)

Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast

Surgery, 2008-03, Vol.143 (3), p.414-425

2008

Volltextzugriff (PDF)

Ribociclib for HR-Positive, Advanced Breast Cancer

The New England journal of medicine, 2017-01, Vol.376 (3), p.288

2017

Volltextzugriff (PDF)

Prediction of Response to Docetaxel by Quantitative Analysis of Class I and III β-Tubulin Isotype mRNA Expression in Human Breast Cancers

Clinical cancer research, 2003-08, Vol.9 (8), p.2992-2997

2003

Volltextzugriff (PDF)

High Expression of Steroid Sulfatase mRNA Predicts Poor Prognosis in Patients with Estrogen Receptor-positive Breast Cancer

Clinical cancer research, 2003-06, Vol.9 (6), p.2288-2293

2003

Volltextzugriff (PDF)

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors

Cancer research (Chicago, Ill.), 2004-03, Vol.64 (6), p.2199-2204

2004

Volltextzugriff (PDF)

A claims data analysis of single institution for comorbidity among various types of cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18843-e18843

2018

Volltextzugriff (PDF)

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial

The Lancet (British edition), 2023-05, Vol.401 (10390), p.1773-1785

2023

Volltextzugriff (PDF)

Tumor Infiltrating Lymphocytes in Luminal A Breast Cancer Is Associated with Cell Proliferation and Worse Survival

Journal of the American College of Surgeons, 2022-11, Vol.235 (5), p.S6-S6

2022

Volltextzugriff (PDF)

Abstract 3813: PHB2 inactivation by AKAP-BIG3 is required for progression of HER2-overexpressing breast cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3813-3813

2019

Volltextzugriff (PDF)

Prognostic value of FDG-PET/CT prior to breast cancer treatment - Comparison with MRS and DWI

The Journal of nuclear medicine (1978), 2019-05, Vol.60

2019

Volltextzugriff (PDF)

Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer

Cancer science, 2003-07, Vol.94 (7), p.606-611

2003

Volltextzugriff (PDF)

1 – 25 von 173

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(153)

Publikationsform

Artikel
(172)
Tagungsberichte
(1)

Sprache

Englisch
(170)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage

Prognostic value of FDG-PET and DWI in breast cancer

Significant association between high serum CCL5 levels and better disease‐free survival of patients with early breast cancer

Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage

Ribociclib for HR-Positive, Advanced Breast Cancer

Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women

HP1 regulates the localization of FANCJ at sites of DNA double‐strand breaks

Therapeutic advances in BIG3‐PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer

Association of Serum Adiponectin Levels with Breast Cancer Risk

Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers

Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling

High Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast Cancer

High expression of ubiquitin carboxy‐terminal hydrolase‐L1 and ‐L3 mRNA predicts early recurrence in patients with invasive breast cancer

High Expression of Wilms’ Tumor Suppressor Gene Predicts Poor Prognosis in Breast Cancer Patients

Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast

Ribociclib for HR-Positive, Advanced Breast Cancer

Prediction of Response to Docetaxel by Quantitative Analysis of Class I and III β-Tubulin Isotype mRNA Expression in Human Breast Cancers

High Expression of Steroid Sulfatase mRNA Predicts Poor Prognosis in Patients with Estrogen Receptor-positive Breast Cancer

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors

A claims data analysis of single institution for comorbidity among various types of cancer

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial

Tumor Infiltrating Lymphocytes in Luminal A Breast Cancer Is Associated with Cell Proliferation and Worse Survival

Abstract 3813: PHB2 inactivation by AKAP-BIG3 is required for progression of HER2-overexpressing breast cancer

Prognostic value of FDG-PET/CT prior to breast cancer treatment - Comparison with MRS and DWI

Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer

Aktive Filter

Suchergebnisse filtern